Mitochondrial Peptides Show Promise for Neurodegenerative Disease Treatment
Mitochondrial-Derived Peptides: Implication in the Therapy of Neurodegenerative Diseases.
Background
Neurodegenerative diseases like Alzheimer's and Parkinson's are characterized by progressive neuronal loss and severe cognitive/motor impairments, often linked to mitochondrial dysfunction (impaired energy production within cells). Current therapies offer limited efficacy, highlighting an urgent need for novel therapeutic strategies. This review explores the therapeutic potential of mitochondrial-derived peptides (MDPs) as a new class of agents to combat these devastating conditions.